Document Page: First | Prev | Next | All | Image | This Release | Search

PRIOR~T~Y       ---.-
                                                              ~   TOD


YO~: ~RQ BEIN~. CI YEN ~ Y~CCINE -C~LLED BOTULINUN TOXOID BEC~USE


P~6E O3-RHIP~~~\\\\ C r.    ~     -  -
YOU ~RE CONSIDERED ~T RIS~; OF EXPOSURE TO BOTULISM.      BOTULISM C~N
L~USE SERIOtj~ P~R~LYSIS OR DE~TH.   JT IS C~USEO BY TOXINS THHT
INTERFERE WITH THE NORM~L TR~NSMISSION OF NERVE SIGN~LS.
BOTtjLIstl C~N ~RISE FROM:
          (1)  CONT~MIN~TED FOOrj ~Nfl W~TER
          (~)  CONT~MINflTED WOiNDS
          (3)  fi BIOLOGIC~L W~RF~RE H~TT~C~:
SYMPTOMS OF BOTULISin C~N BEGIN ~S E~RLY ~S THREE HO(jRS OR ~S L~TE
~S SEVER~L D~Y5 ~FTER EXPOSURE TO THE TOXIN.       SYMPTOMS INCLUDE
BLURRED VISION,   GENER~LI~ED WE~?:::NESS, DIFFICULTY IN SW~LLOWING
HND T~L~ING.    TRE~TMENT ~FTER EXPOSURE IS PRIM~RILY SUPPORTIVE
~ND THERi IS ~N ~NTITOXIN/~NTIDOTE WHICH N~Y BE BENEFICI~L.       YOUR
PRIM~RY PROTECTION ~G~INST BOTULINUM TOXIN IS THE USE OF YOUR
CHEM I C~L PROTECT I YE M~SK 4ND OYERG~RMENT.   Y~CC IN~~I ON WITH
BOTULINUM TOXOID IS EXPECTED TO PROYlDE ~DDITION~L PROTECTION FOR
INDIVIDU~LS EXPOSED TO THE TOXIN.    HOWEYER,    NO Y~iCCINE IS iOo
PERCENT EFFECTIVE.    NO OTHER Y~CCINE IS ~Y~IL~BLE WHICH C~N GIVE
YOU THIS PROTECTION.    THIS IS ~N INYESTIG~TION~L    (NOT YET LICENSED)
Y~CCINE TH~T H~S BEEN S~FELY GIVEN TO OVER 3, QOC) L~BOR~TORY WOR~;ERs
  D SCIENTISTS OYER THE P~ST 25 YE~RS        IT WILL BE ~DMINI~TERED


P~GE C)4 RHIP~~~\\\\ CI 1=
   ~ SERIES OF THREE INJECTIONS UNnER THE SUPERYISION OF
0(~LIFIED MEDIC~L PERSONNEL.   ~BOUT 92 PERCENT OF PEOPLE WHO ~RE
V~CCIN~TED REPORT NO SIGNIFIC~NT SIDE EFFECTS BEYOND THE LOC~L P~IN
EXPERIENCED ~T THE TIME THE YHCCINE IS GIVEN.       HOWEVER, LItE OTHER
Y~CCINES YOU H~VE BEEN GIVEN,   THIS ONE i-1~Y H~YE SOlE SIDE EFFECTS -
SIDE EFFECTS OCCUR IN FOUR PERCENT TO EIGHT PERCENT OF PEOPLE.       WHEN
THEY OCCUR,   THEY HRE USU~LLY ~T THE SITE OF INJECTION ~ND INCLUDE
P~IN,  TENDERNESS,  SWELLING, REDNESS, ~ND/OR ITCHING.     ~LL THESE ,,ThPE
COMMON SYMPTOMS WITH THE TYPHOID Y~CCINE YOU H~YE ~t.RE~DY RECEIVED.
THE NUMBER OF THESE LOC~L RE~CTIONS TENDS TO INCRE~SE ~FTER THE
FIRST INJECTION.   R~RELY ~N INDIVIDtj~L M~Y DEVELOP ~ SM~LL LUMP ~T
THE INJECTION SITE WHICH L~STS FOR SEVER~L D~YS TO WEEtS BEFORE
GOING ~J~Y.   LOC~L RE~CTIONS TH~T C~N INTERFERE WITH PERFORM~NCE OF
YOUR DUTIES ~RE MUSCLE P~IN e~ND OCCUR IN LESS TH~N ONE PERCENT OF
PEOPLE.    R~RELY. (LESS TH~N 1 IN 1 ,OC)C) INJECTIONS) ~N INDIYIDUHL M~Y
BE UN~BLE TO PERFORM DUTIES FOR ~ D~Y OR TWO.       45 WITH H~NY
Y~CCIN4TION,   ~ VERY R~RE, UNEXPECTED, POTENTI~LLY SEVERE,    SIDE
EFFECT NOT PREVIOUSLY OBSERVED COULD OCCUR.       IF YOU 4RE PREGN~NT
IT IS NOT fr:NOWN IF THIS Y4CCINE WILL H4RM YOUR UNBORN B~BY -
HOWEVER, M6ST YHCCINES DO NOT H~RM ~N UNBORN B~BY WHEN GIVEN TO


PRIORITY               ~3I~~~~~Z~~~~~~~~~~~~~~.~.1~X~~~~~~.x~~~.. -~


                 A            -        H

Document Page: First | Prev | Next | All | Image | This Release | Search